Topical carbonic anhydrase inhibitors.
Kass
M A
MA
Department of Ophthalmology, Washington University School of Medicine, St. Louis, MO 63110.
D000287:Administration, Topical; D052160:Benzothiazoles; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005016:Ethoxzolamide / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000627:therapeutic use; D005782:Gels; D005901:Glaucoma / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009798:Ocular Hypertension / Q000188:drug therapy / Q000503:physiopathology; D013449:Sulfonamides / Q000008:administration & dosage* / Q000627:therapeutic use; D013844:Thiazoles / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage* / Q000627:therapeutic use
D052160:Benzothiazoles; D002257:Carbonic Anhydrase Inhibitors; D005782:Gels; D013449:Sulfonamides; D013844:Thiazoles; D013876:Thiophenes; C049027:aminozolamide; C057921:sezolamide; D005016:Ethoxzolamide